Author(s): Wang Yunxia, Department of Nephrology, the People’s Hospital in Jin Hu County, Jiangsu Province
Pages: 69-70
Year: 2014 Issue:  35
Journal: Chinese Community Doctors
Keyword:  Hemoperfusion; Hemodialysis; Cellular immune function;
Abstract: Objective:To discuss the effect of the cellular immune function of hemoperfusion combined with hemodialysis on maintenance hemodialysis patients.Methods:40 patients with maintenance hemodialysis were selected.They were randomly divided into the single hemodialysis group(HD group)and the hemoperfusion combined with hemodialysis group(HP+HD group).Both groups were treated for eight weeks.Monitoring the changes before and after the treatment,patients with CD4,CD8 and CD4/CD8.Results:Before treatment,CD4[(33.18%±5.20%)/(33.09%±4.20%)],CD8[(35.22%±1.05%)/(34.10%±1.14%)]and CD4/CD8[(1.02 ± 0.35)/(1.07 ± 0.38)] of HD group and HP + HD group had no statistical difference(P>0.05).After 8 weeks of treatment, the differences of CD4[(33.53%±6.16%)/(42.92%±8.74%)],CD8[(33.8%±8.37%)/(22.09%±7.52%)],CD4/CD8[(1.06 ± 0.36)比(2.24 ± 1.16)] of two groups were statistically significant(P<0.05).Conclusion:Hemoperfusion combined with hemodialysis on maintenance hemodialysis patients can significantly improve the cell immune function,and improve the therapeutic effect.